Despite collapse of official narrative, Brazil approves use of bivalent Covid-19 vaccine for entire adult population

At a time when more and more evidence is being gathered worldwide that shows the dangers of Covid vaccines, the Lula government announced the expansion of the vaccination campaign against Covid-19 with the bivalent booster dose for the entire population over 18 years of age, which means that about 97 million Brazilians can be vaccinated.

A recently published study from the Cleveland Clinic has questioned COVID-19 vaccine efficacy and posited that additional doses might, in fact, increase one’s likeliness of contracting the disease.

Conducted between September and December of this year, the clinic examined 51,000 employees to test the “bivalent” vaccine, created to protect against the original COVID-19 strain and its Omicron variants.

It also sought to determine the effectiveness of subsequent vaccine doses. The study has not yet been peer-reviewed.

Swiss authorities have stopped recommending vaccination against Covid-19, even for people designated at high risk of contracting the disease.

Consequently, the Swiss Federal Office of Public Health says that “vaccination against COVID-19 is not recommended for spring/summer 2023.”

Nor is it recommended that people designated as high-risk be vaccinated against the coronavirus.

LULA GOVERNMENT IGNORES ALL THE SIGNS

According to the  Brazilian Ministry of Health, however, the bivalent dose can be taken by anyone who has received at least two monovalent vaccines (Coronavac, AstraZeneca, or Pfizer) in the primary or booster schedule.

The most recent dose must have been taken four months ago. Those who have overdue doses can also seek the health units.

The Ministry pointed out that the vaccines have proven to be safe, effective and prevent complications arising from COVID-19.

According to the folder, the expansion aims to strengthen protection against the disease and expand vaccination coverage throughout the country.

The immunization campaign with the bivalent vaccine began in February, targeting the elderly aged 60 years or older, people living in long-stay institutions, immunocompromised people, indigenous people, Maroons, river dwellers, pregnant and puerperal women, health professionals, people with a permanent disability, prisoners and adolescents in socio-educational measures and employees of penitentiary centers.

This article was drafted with automated assistance and reviewed before publication. How we use AI · Report an error